Pemetrexed Plus Platinum for Patients With Advanced Non-small Cell Lung Cancer and Interstitial Lung Disease

被引:11
作者
Fujita, Tetsuo [1 ]
Kuroki, Tsuguko [1 ]
Hayama, Nami [1 ]
Shiraishi, Yuka [1 ]
Amano, Hiroyuki [1 ]
Nakamura, Makoto [1 ]
Hirano, Satoshi [2 ]
Tabeta, Hiroshi [1 ]
Nakamura, Sukeyuki [1 ]
机构
[1] Funabashi Municipal Med Ctr, Dept Respirol, 1-21-1 Kanasugi, Kanasugi, Chiba 2738588, Japan
[2] Funabashi Municipal Med Ctr, Dept Med Oncol, Kanasugi, Japan
来源
IN VIVO | 2019年 / 33卷 / 06期
关键词
Nonsquamous non-small-cell lung cancer; interstitial lung disease; pemetrexed; platinum; PHASE-III; CHEMOTHERAPY; CARBOPLATIN; PACLITAXEL; EFFICACY; SAFETY; BEVACIZUMAB; GEMCITABINE; COMBINATION; CISPLATIN;
D O I
10.21873/invivo.11704
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Pemetrexed plus platinum followed by pemetrexed maintenance has been one of the standard first-line treatments in advanced nonsquamous non-small cell lung cancer (NSCLC), but little is known regarding its safety and efficacy for patients with interstitial lung disease (ILD). Patients and Methods: The medical records of 24 patients with advanced nonsquamous NSCLC and preexisting ILD who received pemetrexed and platinum doublet therapy with and without pemetrexed maintenance in the first-line setting between December 2009 and June 2016, were retrospectively reviewed. Results: The median progression-free survival time was 4.7 months, and the median overall survival time was 9.5 months. Of the 24 patients analyzed, six received pemetrexed maintenance. Acute exacerbation of ILD (AE-ILD) occurred in five (20.8 %) of 24 patients, including two fatal cases. Conclusion: The treatment with pemetrexed plus platinum has a high risk of AE-ILD in patients with advanced nonsquamous NSCLC and preexisting ILD.
引用
收藏
页码:2059 / 2064
页数:6
相关论文
共 20 条
[1]   Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].
Brahmer, Julie ;
Reckamp, Karen L. ;
Baas, Paul ;
Crino, Lucio ;
Eberhardt, Wilfried E. E. ;
Poddubskaya, Elena ;
Antonia, Scott ;
Pluzanski, Adam ;
Vokes, Everett E. ;
Holgado, Esther ;
Waterhouse, David ;
Ready, Neal ;
Gainor, Justin ;
Aren Frontera, Osvaldo ;
Havel, Libor ;
Steins, Martin ;
Garassino, Marina C. ;
Aerts, Joachim G. ;
Domine, Manuel ;
Paz-Ares, Luis ;
Reck, Martin ;
Baudelet, Christine ;
Harbison, Christopher T. ;
Lestini, Brian ;
Spigel, David R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135
[2]   Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease [J].
Choi, Moon Ki ;
Hong, Jung Yong ;
Chang, Wonjin ;
Kim, Moonjin ;
Kim, Sungmin ;
Jung, Hyun Ae ;
Lee, Su Jin ;
Park, Silvia ;
Chung, Man Pyo ;
Sun, Jong-Mu ;
Park, Keunchil ;
Ahn, Myung-Ju ;
Ahn, Jin Seok .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (06) :1217-1225
[3]   Acute exacerbations of idiopathic pulmonary fibrosis [J].
Collard, Harold R. ;
Moore, Bethany B. ;
Flaherty, Kevin R. ;
Brown, Kevin K. ;
Kaner, Robert J. ;
King, Talmadge E., Jr. ;
Lasky, Joseph A. ;
Loyd, James E. ;
Noth, Imre ;
Olman, Mitchell A. ;
Raghu, Ganesh ;
Roman, Jesse ;
Ryu, Jay H. ;
Zisman, David A. ;
Hunninghake, Gary W. ;
Colby, Thomas V. ;
Egan, Jim J. ;
Hansell, David M. ;
Johkoh, Takeshi ;
Kaminski, Naftali ;
Kim, Dong Soon ;
Kondoh, Yasuhiro ;
Lynch, David A. ;
Mueller-Quernheim, Joachim ;
Myers, Jeffrey L. ;
Nicholson, Andrew G. ;
Selman, Moises ;
Toews, Galen B. ;
Wells, Athol U. ;
Martinez, Fernando J. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (07) :636-643
[4]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[5]   The Safety and Efficacy of Treatment with Nab-paclitaxel and Carboplatin for Patients with Advanced Squamous Non-small Cell Lung Cancer Concurrent with Idiopathic Interstitial Pneumonias [J].
Fujita, Tetsuo ;
Hiroishi, Takuma ;
Shikano, Kohei ;
Yanagisawa, Asako ;
Hayama, Noriko ;
Amano, Hiroyuki ;
Nakamura, Makoto ;
Hirano, Satoshi ;
Tabeta, Hiroshi ;
Nakamura, Sukeyuki .
INTERNAL MEDICINE, 2018, 57 (13) :1827-1832
[6]   Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients [J].
Imokawa, S ;
Colby, TV ;
Leslie, KO ;
Helmers, RA .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (02) :373-381
[7]   Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease [J].
Kato M. ;
Shukuya T. ;
Takahashi F. ;
Mori K. ;
Suina K. ;
Asao T. ;
Kanemaru R. ;
Honma Y. ;
Muraki K. ;
Sugano K. ;
Shibayama R. ;
Koyama R. ;
Shimada N. ;
Takahashi K. .
BMC Cancer, 14 (1)
[8]   Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease [J].
Kenmotsu, Hirotsugu ;
Naito, Tateaki ;
Mori, Keita ;
Ko, Ryo ;
Ono, Akira ;
Wakuda, Kazushige ;
Imai, Hisao ;
Taira, Tetsuhiko ;
Murakami, Haruyasu ;
Endo, Masahiro ;
Takahashi, Toshiaki .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) :521-526
[9]   Consensus statement for the diagnosis and treatment of drug-induced lung injuries [J].
Kubo, Keishi ;
Azuma, Arata ;
Kanazawa, Minoru ;
Kameda, Hideto ;
Kusumoto, Masahiko ;
Genma, Akihiko ;
Saijo, Yasuo ;
Sakai, Fumikazu ;
Sugiyama, Yukihiko ;
Tatsumi, Koichiro ;
Dohi, Makoto ;
Tokuda, Hitoshi ;
Hashimoto, Shu ;
Hattori, Noboru ;
Hanaoka, Masayuki ;
Fukuda, Yuh .
RESPIRATORY INVESTIGATION, 2013, 51 (04) :260-277
[10]   Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study [J].
Kudoh, Shoji ;
Kato, Harubumi ;
Nishiwaki, Yutaka ;
Fukuoka, Masahiro ;
Nakata, Kouichiro ;
Ichinose, Yukito ;
Tsuboi, Masahiro ;
Yokota, Soichiro ;
Nakagawa, Kazuhiko ;
Suga, Moritaka ;
Jiang, Haiyi ;
Itoh, Yohji ;
Armour, Alison ;
Watkins, Claire ;
Higenbottam, Tim ;
Nyberg, Fredrik .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (12) :1348-1357